CombiGene – the gene therapy explorer
The goal for CombiGene is to develop treatment methods that can improve
the lives of milions of people all over the world.
Developing new treatment methods for neurological diseases, with higher precision, greater efficacy and fewer side effects.
CombiGene has, by combining advancements in neuroscience and modern gene therapy, developed a treatment method which is shown to prevent epileptic seizures. Currently, the company is focusing on further developing this treatment for the benefit of epilepsy patients, but this method has the potential to be developed for other neurological diseases. CombiGene’s office is located at Medicon Village in Lund and builds on research results from Lund University and the University of Copenhagen.
A STEP BY STEP TREATMENT
The focus for CombiGene is to produce a therapy for epileptic patients who cannot be helped by available medical treatments at present.
Read more »
Combigene AB, Medicon Village, SE-223-81 Lund, Visiting adress: Scheelevägen 2, Lund, Sweden